These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Osteoporosis/osteopenia as an independent factor associated with periodontitis in postmenopausal women: a case-control study. Passos JS; Vianna MI; Gomes-Filho IS; Cruz SS; Barreto ML; Adan L; Rösing CK; Cerqueira EM; Trindade SC; Coelho JM Osteoporos Int; 2013 Apr; 24(4):1275-83. PubMed ID: 23001114 [TBL] [Abstract][Full Text] [Related]
5. [Oral osteoporosis: a review and its dental implications]. Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871 [TBL] [Abstract][Full Text] [Related]
6. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. Reinhardt RA; Payne JB; Maze CA; Patil KD; Gallagher SJ; Mattson JS J Periodontol; 1999 Aug; 70(8):823-8. PubMed ID: 10476887 [TBL] [Abstract][Full Text] [Related]
7. [Changes to the periodontium in postmenopausal women]. Kaźmierczak W; Fiegler P; Przybyłek K; Kamiński K; Fiegler-Mecik H; Wegrzyn P Ginekol Pol; 2005 Feb; 76(2):163-7. PubMed ID: 15847085 [TBL] [Abstract][Full Text] [Related]
8. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517 [TBL] [Abstract][Full Text] [Related]
9. Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment? Laster AJ; Tanner SB Rheum Dis Clin North Am; 2011 Aug; 37(3):323-36, v. PubMed ID: 22023894 [TBL] [Abstract][Full Text] [Related]
10. Combination anabolic and antiresorptive therapy for osteoporosis. Cusano NE; Bilezikian JP Endocrinol Metab Clin North Am; 2012 Sep; 41(3):643-54. PubMed ID: 22877434 [TBL] [Abstract][Full Text] [Related]
11. Periodontal assessment of postmenopausal women receiving risedronate. Palomo L; Bissada NF; Liu J Menopause; 2005; 12(6):685-90. PubMed ID: 16278611 [TBL] [Abstract][Full Text] [Related]
12. Osteoporosis, fragility fracture, and periodontal disease: a cross-sectional study in Spanish postmenopausal women. Martínez-Maestre MA; Machuca G; González-Cejudo C; Flores JR; Cardoso RT; Castelo-Branco C Menopause; 2013 Jan; 20(1):79-84. PubMed ID: 22914207 [TBL] [Abstract][Full Text] [Related]
13. Periodontitis and stroke. Straka M; Trapezanlidis M Neuro Endocrinol Lett; 2013; 34(3):200-6. PubMed ID: 23685417 [TBL] [Abstract][Full Text] [Related]
14. [What to use to treat osteoporosis?]. Välimäki MJ Duodecim; 2003; 119(24):2409-12. PubMed ID: 14870501 [No Abstract] [Full Text] [Related]
15. Osteoporosis: a possible modifying factor in oral bone loss. Jeffcoat MK Ann Periodontol; 1998 Jul; 3(1):312-21. PubMed ID: 9722715 [TBL] [Abstract][Full Text] [Related]
16. [Up-to-date treatments for osteoporosis]. Bors K Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157 [TBL] [Abstract][Full Text] [Related]
17. Oral implications of osteoporosis. Dervis E Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Sep; 100(3):349-56. PubMed ID: 16122665 [TBL] [Abstract][Full Text] [Related]
18. Anabolic therapies for osteoporosis. Uihlein AV; Leder BZ Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427 [TBL] [Abstract][Full Text] [Related]
19. Bone turnover markers: a key tool for understanding osteoporosis. Eastell R; Ebeling PR Osteoporos Int; 2009 May; 20 Suppl 3():S237-8. PubMed ID: 19430871 [No Abstract] [Full Text] [Related]
20. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Josse RG CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]